|
KMID : 1137020070180010039
|
|
Journal of Gynecologic Oncology
2007 Volume.18 No. 1 p.39 ~ p.47
|
|
|
A clinical study of borderline malignant tumors of the ovary
|
|
Jung Nan-Hee
Kim Tak
Lee Kyu-Wan
Kim Hai-Joong
Kim Yun-Ah
Jeong Sang-Geun
Lee Cahn
Lee Nak-Woo
|
|
|
Abstract
|
|
|
Objective: The purpose of this study was to evaluate the clinical and histopathological features, and to find relationship between treatment modality and prognosis of borderline ovarian tumors.
Methods: Ninety-three cases of borderline ovarian tumors that had been treated were reviewed retrospectively.
Results: Histologic types of this study group composed of 67 cases of mucinous borderline tumor, 23 cases of serous borderline tumor, 2 cases of mixed type, and 1 case of Brenner tumor. The mean age was 41.6 years (range 14 to 83), and 41 (44.1 %) patients were nullipara. The most common chief complaint was palpable mass (39.8%) and asymptomatic cases were presented in 23 patients (24.7%). The cases of elevated serum CA125 (≥35 IU/㎖) were 25.8% in mucinous type and 61.9% in serous type. Surgical staging was completed in 57 cases and other 36 cases were incompletely staged. 45 cases were managed by conservative surgery. There were 4 cases with recurrence, and all of them were related to conservative surgery. Chemotherapy was given to 40 cases. Mean follow-up period was 27.3 months. One patient expired during follow-up, and overall 5-year survival rate was 95.2%.
Conclusion: Borderline ovarian tumors have a good prognosis. But recurrence rate was high in conservative surgery. In conclusion, careful preoperative evaluations, complete surgical exploration and long-term follow-up after treatment are needed.
|
|
|
KEYWORD
|
|
|
Borderline ovarian tumor, Surgical staging, Clinical study, Prognosis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
    
|